Qiming U.s. Ventures Management, LLC

Investment Portfolio & 13F Holdings Analysis

About

CIK: 0001909617

Type: FundHoldings: 6Value: $23.1MLatest: 2025Q1

Qiming U.S. Ventures Management, LLC is an institutional investment manager that filed its latest Form 13F for 2025Q1, reporting 6 holdings worth $0.0 billion. Form 13F filings provide transparency into the equity holdings of institutional investment managers with over $100 million in assets under management. This page displays the most recent portfolio holdings, allowing investors to track position changes, new investments, and portfolio composition.

AI_NATIVE detailed information: This accession holds the following tickers:[
  "TRML",
  "JSPR",
  "KRRO",
  "HLVX",
  "KZR",
  "VTYX"
]

Filing Details

13F-HR • 2025-03-31

SEC FilingSEC DataHachi Filing

Report Date: 2025-03-31
Filing Date: 2025-05-15
Total Holdings: 6
Total Value: 23102786
Accession Number: 0001415889-25-013135
Form Type: 13F-HR
CIK: qiming-us-ventures-management
Manager Name: Qiming-Us-Ventures-Management

Data Enrichment

100% identified

6 identified0 unidentified

Holdings

SEC FilingSEC DataHachi Filing

Manager:

6 positions • $23.1M total value

SEC FilingSEC DataHachi Filing

Manager:

Search and click to pin securities to the top

Sort by:

Tourmaline Bio, Inc.

TRML|89157D105

Shares:741.7K

Value:$11.3M

% of Portfolio:48.8% ($11.3M/$23.1M)

Korro Bio, Inc.

KRRO|500946108

Shares:368.1K

Value:$6.4M

% of Portfolio:27.7% ($6.4M/$23.1M)

Jasper Therapeutics, Inc.

JSPR|471871202

Shares:929.0K

Value:$4.0M

% of Portfolio:17.3% ($4.0M/$23.1M)

HilleVax, Inc.

HLVX|43157M102

Shares:372.6K

Value:$540.3K

% of Portfolio:2.3% ($540.3K/$23.1M)

Ventyx Biosciences, Inc.

VTYX|92332V107

Shares:412.2K

Value:$474.1K

% of Portfolio:2.1% ($474.1K/$23.1M)

Kezar Life Sciences, Inc.

KZR|49372L209

Shares:82.9K

Value:$404.4K

% of Portfolio:1.8% ($404.4K/$23.1M)

Instrument	Shares		Other Manager	Value	% of Portfolio
Tourmaline Bio, Inc.(TRMLcusip89157D105)	741.7K	QoQ 0.00% (-0) YoY 0.00% (-0)	All Managers (Combined)	$11.3M	48.8% ($11.3M/$23.1M)	QoQ -24.99% (-$3.8M) YoY -33.58% (-$5.7M)
Korro Bio, Inc.(KRROcusip500946108)	368.1K	QoQ 0.00% (-0) YoY 0.00% (-0)	All Managers (Combined)	$6.4M	27.7% ($6.4M/$23.1M)	QoQ -54.26% (-$7.6M) YoY -80.65% (-$26.7M)
Jasper Therapeutics, Inc.(JSPRcusip471871202)	929.0K	QoQ 0.00% (-0) YoY 0.00% (-0)	All Managers (Combined)	$4.0M	17.3% ($4.0M/$23.1M)	QoQ -79.88% (-$15.9M) YoY -85.35% (-$23.3M)
HilleVax, Inc.(HLVXcusip43157M102)	372.6K	QoQ 0.00% (-0) YoY -33.33% (-186.3K)	All Managers (Combined)	$540.3K	2.3% ($540.3K/$23.1M)	QoQ -29.95% (-$231.0K) YoY -94.18% (-$8.8M)
Ventyx Biosciences, Inc.(VTYXcusip92332V107)	412.2K	QoQ 0.00% (-0) YoY 0.00% (-0)	All Managers (Combined)	$474.1K	2.1% ($474.1K/$23.1M)	QoQ -47.48% (-$428.7K) YoY -79.09% (-$1.8M)
Kezar Life Sciences, Inc.(KZRcusip49372L209)	82.9K	QoQ 0.00% (-0) YoY NEW(+82.9K)	All Managers (Combined)	$404.4K	1.8% ($404.4K/$23.1M)	QoQ -27.38% (-$152.5K) YoY NEW(+$404.4K)